(Reuters) — Human testing of an experimental Ebola vaccine developed by the Canadian health agency and licensed to NewLink Genetics Corp has begun, the Canadian government announced on Monday (October 13) The early-stage trial will test the vaccine, VSV-EBOV, on a small group of people to determine whether the vaccine is safe and the appropriate dose necessary to provide immunity, officials said. Canada’s Public Health Agency has been working on the vaccine for years, local media reported. Speaking in Toronto, Chief Public Health Officer, […]